Browse studies

Find your next paid study

3,846 recruiting studies matching your filters

A Pilot Trial to Evaluate the Effectiveness of Navigation, Interactive Web Education, or the Combination of Both to Promote Guideline-Concordant Colorectal Cancer Surveillance Care

This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC),…

Stage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8

Estimated

~$10 – $6,250

Fred Hutchinson Cancer CenterNCT06995924

Phase 1

Phase 1b/2 Study of Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

By doing this study, it is the hope to learn whether an injection of the measles, mumps, rubella (MMR) vaccine developed by Merck \& Co. (Merck's M-M-R® II) in…

Borderline Resectable/Unresectable Pancreatic CancerNon Metastatic Pancreatic Cancer

Estimated

~$10 – $6,250

University of ArkansasNCT07539155

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific e…

SurvivorshipRecurrentRecurrence+2 more

Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT07030686

Phase 2

A Phase II Study Assessing the Efficacy of BRain-AVOidant Proton Craniospinal Irradiation (CSI) for Leptomeningeal Metastases (LM) From Solid Tumor Malignancies (BRAVO-LM)

The purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal…

Leptomeningeal MetastasisBreast CancerLung Cancer (NSCLC)

Estimated

~$10 – $6,250

University of MiamiNCT07789912

Observational

Chicago Alternative Prevention Study for BreAst CAncer inHigh Risk Women - CAPSBRACA

This study is aimed to establish a registry of women undergoing intensive surveillance for the early detection of breast cancer in high-risk women.

Breast Cancer

Estimated

~$10 – $6,250

University of ChicagoNCT03729115

Phase 3

Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort)

The goal of this study is to learn methods doctors can use to help improve the cystoscopy experience. Specifically, this study will determine if listening to m…

Bladder (Urothelial, Transitional Cell) CancerHematuria

Estimated

~$10 – $7,500

Florian SchroeckNCT07795255

Phase 1

A Multicenter, Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Activity of TUB-040, in Combination With Standard Ovarian Cancer Drugs in Patients With High-grade Epithelial Serous or Endometrioid Epithelial Ovarian Cancer OC)

The goal of this clinical study is to learn more about the safety, tolerability, and preliminary effectiveness of TUB-040 when given in combination with standa…

Ovarian Cancer

Estimated

~$10 – $8,750

Tubulis GmbHNCT07736937

Phase 3

A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Global, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and safety of firmonertinib at a dose level of 240 mg QD compared to investi…

Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more

Estimated

~$10 – $8,750

ArriVent BioPharma, Inc.NCT07185997

Observational

Optimizing Cancer Support Services Usage in Patients With Head and Neck Cancer During the Prehabilitation Period

The purpose of this research is to help researchers understand the barriers, supports, and preferences for prehabilitation. Prehabilitation in this study means…

Head and Neck Cancer

Estimated

~$10 – $6,250

University of MiamiNCT07318220

Observational

Colon Health Champion Program

This is a single arm-proof-of-concept trial. The primary goal of this trial is to assess the feasibility and acceptability of the Colon Health Champion Program

Colorectal CancerCRC

Estimated

~$10 – $6,250

Virginia Commonwealth UniversityNCT07796334

Phase 2

A Randomized Phase II Trial of Neoadjuvant Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Researchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen d…

Prostate CancerProstate Adenocarcinoma

Estimated

~$10 – $6,250

University of ChicagoNCT05726292

Phase 1

Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)

This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in patients with a history of prostate cancer or low-…

Prostate Cancer

Estimated

~$10 – $6,250

Milton S. Hershey Medical CenterNCT06600698